Answers are grounded in this paper and cite their sources.
Randomized trial compares MACE rates between drug-coated balloon and drug-eluting stent interventions, suggesting physiologic assessment in stentless strategies.
Background Physiology-guided drug eluting stent percutaneous coronary intervention (ph DES-PCI) improves cardiovascular outcomes; however, the clinical benefit of ph drug coated balloon PCI (ph DCB-PCI) remains unclear. Results A propensity-matched analysis of 39 patient pairs (ph DCB-PCI versus ph DES-PCI) from the PROPHET-FFR registry was performed. At 13 months, the MACE rate was similar between the groups (5.1 versus 7.6%, P = 0.644), principally driven by target-vessel revascularization (2.6 versus 7.6%, P = 0.305). A single periprocedural myocardial infarction occurred in the ph DCB-PCI group ( P = 0.314). Major findings Ph DCB-PCI appears feasible in selected patients, with no apparent signal of worse outcomes compared with ph DES-PCI, supporting a potential role for physiological assessment in stentless revascularization strategies.
No takes yet. Share an insight, caveat, or question.
Galante et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: